P025 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Induction in the Phase 3 True North Study

Affiliations

• ¹ University of California San Diego, San Diego, United States.
• ² Inflammatory Bowel Disease Center, Amsterdam University Medical Center, Amsterdam, Netherlands.
• ³ Center for Crohn's Disease & Ulcerative Colitis, Atlanta Gastroenterology Associates, Atlanta, United States.
• ⁴ Feinberg School of Medicine, Chicago, United States.
• ⁵ University of Belgrade Medical School, Belgrade, Serbia.
• ⁶ University of Calgary, Calgary, Canada.
• ⁷ Bristol-Myers Squibb Company, Princeton, United States.
• ⁸ Humanitas Clinical and Research Center, Milan, Italy.
• ⁹ Western University, London, Canada.